Search results
Study Examines How Speech Patterns Change With Age
MedPage Today· 2 days agoAt the American Academy of Neurology annual meeting, researchers presented a study involving cognitively normal individuals ...
‘Liquid gold’ could bring new hope to multiple sclerosis patients, study suggests: ‘Profound...
Fox News· 4 days agoThe "catalytically active" liquid, developed by Clene Nanomedicine in North East, Maryland, can...
Major Gaps in Care, Management of Neurologic Diseases
Medscape· 4 days agoWin, PhD, medical manager/team lead, OMNI Scientific Strategy and Collaborations, US Medical...
...From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing...Sclerosis in the Peer Reviewed...
FOX 4 Kansas City· 4 days agoThe paper, lead authored by coordinating investigator, Robert J. Fox, M.D., Staff Neurologist, Mellen Center for Multiple Sclerosis, Vice...
Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal
Proactive Investors· 4 days agoImmunic Inc (NASDAQ:IMUX) CEO Dr Daniel Vitt joined Proactive's Stephen Gunnion with news of the...
Immunic publishes extended data from Phase 2 MS trial in peer-reviewed journal
Proactive Investors· 4 days agoImmunic is developing its small molecule investigational drug vidofludimus calcium as an oral...
Longboard Pharmaceuticals Inc. (LBPH) Q1 2024 Earnings: Financial and Strategic Developments
GuruFocus.com via Yahoo Finance· 11 hours agoThe company reported positive topline data from the PACIFIC Study of bexicaserin at the American Academy of
These Incredibly Popular Drugs Have Been Linked to Migraines
SciTechDaily· 7 days agoAccording to research published in Neurology Clinical Practice, an official journal of the American Academy
New clinical practice guideline provides evidence-based recommendations for age-related hearing loss
Medical Xpress· 4 days agoThe American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF) has published...
Mullen (NASDAQ: MULN) Partners with Pritchard EV, MRSS to Target 'Great Opportunity' within Roadside...
Digital Journal· 1 day ago...Batch Completion for NDA Application to FDA Clene (NASDAQ: CLNN) Presents Findings on Phase 2 VISIONARY-MS LTE at American Academy of Neurology Annual Meeting Freight Technologies (NASDAQ: FRGT) Reports 30% YOY Revenue Growth for Q1 2024 Longeveron (NASDAQ...